| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 7.73e-05 | 3 | 102 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | purine-rich negative regulatory element binding | 1.54e-04 | 4 | 102 | 2 | GO:0032422 | |
| GeneOntologyMolecularFunction | alkylglycerophosphoethanolamine phosphodiesterase activity | 2.56e-04 | 5 | 102 | 2 | GO:0047391 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 2.74e-04 | 25 | 102 | 3 | GO:0031683 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating dopamine receptor signaling pathway | 9.94e-06 | 9 | 103 | 3 | GO:0060158 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock | 1.45e-05 | 30 | 103 | 4 | GO:0009649 | |
| GeneOntologyBiologicalProcess | ion channel modulating, G protein-coupled receptor signaling pathway | 2.57e-05 | 12 | 103 | 3 | GO:0099105 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway | 3.34e-05 | 13 | 103 | 3 | GO:0007207 | |
| HumanPheno | Choroidal melanoma | 2.94e-06 | 5 | 35 | 3 | HP:0012054 | |
| HumanPheno | Ciliary body melanoma | 2.94e-06 | 5 | 35 | 3 | HP:0012055 | |
| HumanPheno | Iris melanoma | 2.94e-06 | 5 | 35 | 3 | HP:0011524 | |
| HumanPheno | Abnormal visual accommodation | 2.94e-06 | 5 | 35 | 3 | HP:0030800 | |
| HumanPheno | Inferior lens subluxation | 2.94e-06 | 5 | 35 | 3 | HP:0008494 | |
| HumanPheno | Abnormal ciliary body morphology | 5.86e-06 | 6 | 35 | 3 | HP:0012776 | |
| HumanPheno | Uveal melanoma | 1.63e-05 | 8 | 35 | 3 | HP:0007716 | |
| HumanPheno | Lens subluxation | 1.28e-04 | 15 | 35 | 3 | HP:0001132 | |
| HumanPheno | Mydriasis | 1.57e-04 | 16 | 35 | 3 | HP:0011499 | |
| HumanPheno | Vitreous hemorrhage | 2.26e-04 | 18 | 35 | 3 | HP:0007902 | |
| Domain | ETS_DOMAIN_1 | 1.45e-10 | 28 | 104 | 7 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 1.45e-10 | 28 | 104 | 7 | PS00346 | |
| Domain | ETS | 1.45e-10 | 28 | 104 | 7 | SM00413 | |
| Domain | Ets_dom | 1.45e-10 | 28 | 104 | 7 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 1.45e-10 | 28 | 104 | 7 | PS50061 | |
| Domain | Ets | 1.45e-10 | 28 | 104 | 7 | PF00178 | |
| Domain | Gprotein_alpha_Q | 6.68e-07 | 4 | 104 | 3 | IPR000654 | |
| Domain | ETV3 | 3.07e-05 | 2 | 104 | 2 | IPR032929 | |
| Domain | Cadherin_tail | 5.20e-05 | 37 | 104 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 5.20e-05 | 37 | 104 | 4 | IPR031904 | |
| Domain | LY | 7.27e-05 | 15 | 104 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 7.27e-05 | 15 | 104 | 3 | IPR000033 | |
| Domain | G-alpha | 8.91e-05 | 16 | 104 | 3 | PF00503 | |
| Domain | GproteinA_insert | 8.91e-05 | 16 | 104 | 3 | IPR011025 | |
| Domain | - | 8.91e-05 | 16 | 104 | 3 | 1.10.400.10 | |
| Domain | G_alpha | 8.91e-05 | 16 | 104 | 3 | SM00275 | |
| Domain | InsP3_rcpt-bd | 9.18e-05 | 3 | 104 | 2 | IPR000493 | |
| Domain | SSDP_DNA-bd | 9.18e-05 | 3 | 104 | 2 | IPR008116 | |
| Domain | Gprotein_alpha_su | 1.08e-04 | 17 | 104 | 3 | IPR001019 | |
| Domain | - | 2.18e-04 | 218 | 104 | 7 | 1.10.10.10 | |
| Domain | Cadherin_CS | 3.59e-04 | 109 | 104 | 5 | IPR020894 | |
| Domain | WHTH_DNA-bd_dom | 4.11e-04 | 242 | 104 | 7 | IPR011991 | |
| Domain | CADHERIN_1 | 4.24e-04 | 113 | 104 | 5 | PS00232 | |
| Domain | Cadherin | 4.24e-04 | 113 | 104 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 4.41e-04 | 114 | 104 | 5 | PS50268 | |
| Domain | - | 4.41e-04 | 114 | 104 | 5 | 2.60.40.60 | |
| Domain | RIH_assoc | 4.54e-04 | 6 | 104 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 4.54e-04 | 6 | 104 | 2 | IPR013662 | |
| Domain | RIH_dom | 4.54e-04 | 6 | 104 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.54e-04 | 6 | 104 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.54e-04 | 6 | 104 | 2 | IPR015925 | |
| Domain | - | 4.54e-04 | 6 | 104 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.54e-04 | 6 | 104 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 4.54e-04 | 6 | 104 | 2 | PF08709 | |
| Domain | CA | 4.59e-04 | 115 | 104 | 5 | SM00112 | |
| Domain | Cadherin_2 | 4.73e-04 | 65 | 104 | 4 | PF08266 | |
| Domain | Cadherin_N | 4.73e-04 | 65 | 104 | 4 | IPR013164 | |
| Domain | Cadherin-like | 4.78e-04 | 116 | 104 | 5 | IPR015919 | |
| Domain | Cadherin | 5.17e-04 | 118 | 104 | 5 | IPR002126 | |
| Domain | P-loop_NTPase | DNAH3 HS6ST2 DDX60 RNF213 MYO1B PFKFB4 GNA14 TJP1 MYO3B GNA11 GNAQ SEPTIN7 DNAH9 | 8.53e-04 | 848 | 104 | 13 | IPR027417 |
| Domain | - | 1.33e-03 | 39 | 104 | 3 | 2.120.10.30 | |
| Domain | MIR | 1.34e-03 | 10 | 104 | 2 | PS50919 | |
| Domain | MIR | 1.34e-03 | 10 | 104 | 2 | PF02815 | |
| Domain | MIR | 1.34e-03 | 10 | 104 | 2 | SM00472 | |
| Domain | MIR_motif | 1.34e-03 | 10 | 104 | 2 | IPR016093 | |
| Domain | PNT | 1.63e-03 | 11 | 104 | 2 | PS51433 | |
| Domain | Pointed_dom | 1.63e-03 | 11 | 104 | 2 | IPR003118 | |
| Domain | SAM_PNT | 1.63e-03 | 11 | 104 | 2 | PF02198 | |
| Domain | SAM_PNT | 1.63e-03 | 11 | 104 | 2 | SM00251 | |
| Domain | Sulfotransfer_2 | 1.95e-03 | 12 | 104 | 2 | PF03567 | |
| Domain | Sulfotransferase | 1.95e-03 | 12 | 104 | 2 | IPR005331 | |
| Domain | Quinoprot_gluc/sorb_DH | 1.95e-03 | 12 | 104 | 2 | IPR011041 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.14e-03 | 46 | 104 | 3 | IPR011042 | |
| Domain | OLF | 2.30e-03 | 13 | 104 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 2.30e-03 | 13 | 104 | 2 | IPR003112 | |
| Domain | OLF | 2.30e-03 | 13 | 104 | 2 | SM00284 | |
| Domain | OLF | 2.30e-03 | 13 | 104 | 2 | PF02191 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.68e-03 | 14 | 104 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.68e-03 | 14 | 104 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.68e-03 | 14 | 104 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.68e-03 | 14 | 104 | 2 | PF08393 | |
| Domain | MT | 2.68e-03 | 14 | 104 | 2 | PF12777 | |
| Domain | AAA_8 | 2.68e-03 | 14 | 104 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.68e-03 | 14 | 104 | 2 | IPR011704 | |
| Domain | Ldl_recept_b | 2.68e-03 | 14 | 104 | 2 | PF00058 | |
| Domain | LDLRB | 2.68e-03 | 14 | 104 | 2 | PS51120 | |
| Domain | AAA_5 | 2.68e-03 | 14 | 104 | 2 | PF07728 | |
| Domain | DHC_fam | 3.08e-03 | 15 | 104 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.08e-03 | 15 | 104 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 3.08e-03 | 15 | 104 | 2 | PF03028 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 4.04e-06 | 22 | 71 | 4 | M39795 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 4.99e-06 | 50 | 71 | 5 | M47951 | |
| Pathway | PID_S1P_S1P2_PATHWAY | 5.82e-06 | 24 | 71 | 4 | M268 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 6.73e-06 | 8 | 71 | 3 | MM15032 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 6.73e-06 | 8 | 71 | 3 | M27356 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 6.73e-06 | 8 | 71 | 3 | MM15100 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 7.33e-06 | 54 | 71 | 5 | M26911 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.34e-05 | 61 | 71 | 5 | MM15071 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.43e-05 | 10 | 71 | 3 | M47661 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 1.43e-05 | 10 | 71 | 3 | M1825 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 1.96e-05 | 11 | 71 | 3 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 1.96e-05 | 11 | 71 | 3 | MM15035 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.96e-05 | 11 | 71 | 3 | M49033 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.03e-05 | 72 | 71 | 5 | MM14631 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 3.38e-05 | 13 | 71 | 3 | M47656 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 4.46e-05 | 78 | 71 | 5 | M1921 | |
| Pathway | PID_THROMBIN_PAR4_PATHWAY | 5.33e-05 | 15 | 71 | 3 | M138 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 8.86e-05 | 90 | 71 | 5 | M6467 | |
| Pathway | KEGG_GAP_JUNCTION | 8.86e-05 | 90 | 71 | 5 | M4013 | |
| Pathway | WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING | 1.31e-04 | 20 | 71 | 3 | M39485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.31e-04 | 20 | 71 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 1.53e-04 | 21 | 71 | 3 | M47638 | |
| Pathway | PID_S1P_META_PATHWAY | 1.53e-04 | 21 | 71 | 3 | M155 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 1.53e-04 | 21 | 71 | 3 | M47689 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.53e-04 | 101 | 71 | 5 | M1979 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.76e-04 | 22 | 71 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.76e-04 | 22 | 71 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.02e-04 | 23 | 71 | 3 | M47676 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.09e-04 | 108 | 71 | 5 | M17034 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 2.30e-04 | 24 | 71 | 3 | M13115 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 2.30e-04 | 24 | 71 | 3 | MM15088 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 2.30e-04 | 24 | 71 | 3 | M18308 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 2.30e-04 | 24 | 71 | 3 | MM14794 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 2.48e-04 | 5 | 71 | 2 | M49000 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 2.60e-04 | 25 | 71 | 3 | MM15056 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 2.60e-04 | 25 | 71 | 3 | M811 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.70e-04 | 178 | 71 | 6 | M2890 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 3.70e-04 | 6 | 71 | 2 | M47548 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 3.70e-04 | 6 | 71 | 2 | M47960 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 4.07e-04 | 29 | 71 | 3 | M55 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 4.22e-04 | 70 | 71 | 4 | M8232 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.21e-04 | 74 | 71 | 4 | MM15962 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 5.47e-04 | 32 | 71 | 3 | M861 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 5.47e-04 | 32 | 71 | 3 | MM15148 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 5.99e-04 | 33 | 71 | 3 | MM15020 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 5.99e-04 | 33 | 71 | 3 | M9379 | |
| Pathway | PID_ARF6_PATHWAY | 7.14e-04 | 35 | 71 | 3 | M86 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 8.41e-04 | 37 | 71 | 3 | M42558 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 8.80e-04 | 9 | 71 | 2 | M47852 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY | 8.80e-04 | 9 | 71 | 2 | M47732 | |
| Pathway | REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING | 9.10e-04 | 38 | 71 | 3 | M27656 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 9.82e-04 | 39 | 71 | 3 | MM14496 | |
| Pathway | REACTOME_CHAPERONIN_MEDIATED_PROTEIN_FOLDING | 9.82e-04 | 39 | 71 | 3 | MM15003 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 1.06e-03 | 40 | 71 | 3 | M41 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 1.09e-03 | 90 | 71 | 4 | MM15882 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.10e-03 | 10 | 71 | 2 | MM14956 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 1.14e-03 | 91 | 71 | 4 | M39426 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 1.31e-03 | 43 | 71 | 3 | M238 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 1.34e-03 | 11 | 71 | 2 | M47637 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.34e-03 | 11 | 71 | 2 | M27466 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.34e-03 | 11 | 71 | 2 | M9990 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.40e-03 | 44 | 71 | 3 | M39845 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 1.60e-03 | 12 | 71 | 2 | M47649 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.88e-03 | 13 | 71 | 2 | M39589 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.88e-03 | 13 | 71 | 2 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.88e-03 | 13 | 71 | 2 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.88e-03 | 13 | 71 | 2 | MM14553 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.99e-03 | 261 | 71 | 6 | M42565 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.40e-03 | 271 | 71 | 6 | MM15406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 2.66e-03 | 55 | 71 | 3 | M47952 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 2.68e-03 | 115 | 71 | 4 | M9387 | |
| Pathway | PID_TXA2PATHWAY | 2.80e-03 | 56 | 71 | 3 | M99 | |
| Pathway | WP_ID_SIGNALING | 2.87e-03 | 16 | 71 | 2 | M39359 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.87e-03 | 16 | 71 | 2 | M26945 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.25e-03 | 288 | 71 | 6 | M16864 | |
| Pubmed | 2.94e-10 | 29 | 105 | 6 | 17907201 | ||
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 6.68e-10 | 15 | 105 | 5 | 28578927 | |
| Pubmed | ETS-dependent regulation of a distal Gata4 cardiac enhancer. | 9.25e-09 | 24 | 105 | 5 | 22056786 | |
| Pubmed | 2.55e-08 | 29 | 105 | 5 | 26097038 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 31189994 | ||
| Pubmed | Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. | 1.07e-07 | 4 | 105 | 3 | 20517297 | |
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 9765251 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 35212356 | ||
| Pubmed | Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice. | 1.07e-07 | 4 | 105 | 3 | 9687499 | |
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 27089234 | ||
| Pubmed | Loss of gq/11 genes does not abolish melanopsin phototransduction. | 2.66e-07 | 5 | 105 | 3 | 24870805 | |
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 24970262 | ||
| Pubmed | An Acetate-Specific GPCR, FFAR2, Regulates Insulin Secretion. | 2.66e-07 | 5 | 105 | 3 | 26075576 | |
| Pubmed | Using siRNA to define functional interactions between melanopsin and multiple G Protein partners. | 5.31e-07 | 6 | 105 | 3 | 24958088 | |
| Pubmed | A novel zinc finger gene is fused to EWS in small round cell tumor. | 5.31e-07 | 6 | 105 | 3 | 10949935 | |
| Pubmed | Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients. | 5.31e-07 | 6 | 105 | 3 | 31614358 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 1.46e-06 | 264 | 105 | 8 | 32814769 | |
| Pubmed | Protease-activated receptors in hemostasis, thrombosis and vascular biology. | 2.22e-06 | 9 | 105 | 3 | 16102047 | |
| Pubmed | Phospholipase C-beta 1 is a GTPase-activating protein for Gq/11, its physiologic regulator. | 2.22e-06 | 9 | 105 | 3 | 1322796 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 ATRN LAMB4 DNAH3 DSP VPS13C NEXMIF RNF213 ITPR2 MYO3B NUP188 DOP1B | 2.39e-06 | 736 | 105 | 12 | 29676528 |
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 8588930 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 4.33e-06 | 11 | 105 | 3 | 9655502 | |
| Pubmed | 7.48e-06 | 13 | 105 | 3 | 25802403 | ||
| Pubmed | GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis. | 9.03e-06 | 2 | 105 | 2 | 27498141 | |
| Pubmed | The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan. | 9.03e-06 | 2 | 105 | 2 | 28248732 | |
| Pubmed | Uveal Melanoma: GNAQ and GNA11 Mutations in a Greek Population. | 9.03e-06 | 2 | 105 | 2 | 28982892 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21083380 | ||
| Pubmed | Activation of Gq/11 in the mouse corpus luteum is required for parturition. | 9.03e-06 | 2 | 105 | 2 | 25495873 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 24072183 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25304237 | ||
| Pubmed | Epidermal loss of Gαq confers a migratory and differentiation defect in keratinocytes. | 9.03e-06 | 2 | 105 | 2 | 28301547 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 16847339 | ||
| Pubmed | Uveal melanoma driver mutations in GNAQ/11 yield numerous changes in melanocyte biology. | 9.03e-06 | 2 | 105 | 2 | 29570931 | |
| Pubmed | Muscarinic inhibition of calcium current and M current in Galpha q-deficient mice. | 9.03e-06 | 2 | 105 | 2 | 10818132 | |
| Pubmed | Endothelial Gαq/11 is required for VEGF-induced vascular permeability and angiogenesis. | 9.03e-06 | 2 | 105 | 2 | 26272756 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31461351 | ||
| Pubmed | Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis. | 9.03e-06 | 2 | 105 | 2 | 28248553 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23634288 | ||
| Pubmed | Frequent GNAQ and GNA14 Mutations in Hepatic Small Vessel Neoplasm. | 9.03e-06 | 2 | 105 | 2 | 29975248 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26368812 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17482476 | ||
| Pubmed | Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens. | 9.03e-06 | 2 | 105 | 2 | 21945171 | |
| Pubmed | Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations. | 9.03e-06 | 2 | 105 | 2 | 24141786 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 18708078 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9175863 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15201137 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 29574926 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28083870 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 9.03e-06 | 2 | 105 | 2 | 23582047 | |
| Pubmed | Stretch regulates alveologenesis and homeostasis via mesenchymal Gαq/11-mediated TGFβ2 activation. | 9.03e-06 | 2 | 105 | 2 | 37102682 | |
| Pubmed | Gq/11-Dependent Changes in the Murine Ovarian Transcriptome at the End of Gestation. | 9.03e-06 | 2 | 105 | 2 | 26843449 | |
| Pubmed | Direct targeting of Gαq and Gα11 oncoproteins in cancer cells. | 9.03e-06 | 2 | 105 | 2 | 30890659 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 7492305 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 24308950 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 10704859 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22562663 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 30500808 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19666492 | ||
| Pubmed | Transdifferentiation of erythroblasts to megakaryocytes using FLI1 and ERG transcription factors. | 9.03e-06 | 2 | 105 | 2 | 26063314 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11826096 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21366456 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 35580369 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9607776 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31726051 | ||
| Pubmed | Papillary Hemangioma Harbors Somatic GNA11 and GNAQ Mutations. | 9.03e-06 | 2 | 105 | 2 | 37750536 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11438569 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 37802294 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26778290 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26628681 | ||
| Pubmed | Skeletal Muscle-Specific Activation of Gq Signaling Maintains Glucose Homeostasis. | 9.03e-06 | 2 | 105 | 2 | 30936140 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17552882 | ||
| Pubmed | Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins. | 9.03e-06 | 2 | 105 | 2 | 33275876 | |
| Pubmed | Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11. | 9.03e-06 | 2 | 105 | 2 | 23778528 | |
| Pubmed | High throughput mass spectrometry-based mutation profiling of primary uveal melanoma. | 9.03e-06 | 2 | 105 | 2 | 22977135 | |
| Pubmed | An experimental strategy to probe Gq contribution to signal transduction in living cells. | 9.03e-06 | 2 | 105 | 2 | 33639168 | |
| Pubmed | GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma. | 9.03e-06 | 2 | 105 | 2 | 32064597 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23572068 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31173078 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25695059 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 9.03e-06 | 2 | 105 | 2 | 19120126 | |
| Pubmed | Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas. | 9.03e-06 | 2 | 105 | 2 | 29209985 | |
| Pubmed | ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors. | 9.03e-06 | 2 | 105 | 2 | 26122367 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12351712 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20198559 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26476043 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 29892795 | ||
| Pubmed | GNA14 and GNAQ somatic mutations cause spinal and intracranial extra-axial cavernous hemangiomas. | 9.03e-06 | 2 | 105 | 2 | 38917801 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 36440997 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15713647 | ||
| Pubmed | Distinct roles of Galpha(q) and Galpha11 for Purkinje cell signaling and motor behavior. | 9.03e-06 | 2 | 105 | 2 | 15175381 | |
| Pubmed | GNAQ and GNA11 mutations in melanocytomas of the central nervous system. | 9.03e-06 | 2 | 105 | 2 | 22307269 | |
| Pubmed | Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese. | 9.03e-06 | 2 | 105 | 2 | 25280020 | |
| Pubmed | Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. | 9.50e-06 | 14 | 105 | 3 | 14635793 | |
| Pubmed | 1.18e-05 | 15 | 105 | 3 | 7937899 | ||
| Pubmed | 1.18e-05 | 15 | 105 | 3 | 11118617 | ||
| Pubmed | 1.18e-05 | 15 | 105 | 3 | 15640798 | ||
| Pubmed | 1.76e-05 | 17 | 105 | 3 | 29911975 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 2.11e-05 | 18 | 105 | 3 | 15570159 | |
| Pubmed | TIF1gamma controls erythroid cell fate by regulating transcription elongation. | 2.11e-05 | 18 | 105 | 3 | 20603019 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 2.11e-05 | 18 | 105 | 3 | 10662547 | |
| Cytoband | 5q31 | 1.47e-04 | 115 | 105 | 4 | 5q31 | |
| Cytoband | 9q21 | 2.81e-04 | 11 | 105 | 2 | 9q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 1.85e-03 | 226 | 105 | 4 | chr1q23 | |
| Cytoband | 1q25.1 | 2.77e-03 | 34 | 105 | 2 | 1q25.1 | |
| GeneFamily | ETS transcription factor family | 7.74e-12 | 28 | 67 | 7 | 534 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 4.05e-05 | 3 | 67 | 2 | 297 | |
| GeneFamily | Clustered protocadherins | 9.26e-05 | 64 | 67 | 4 | 20 | |
| GeneFamily | Dyneins, axonemal | 1.77e-03 | 17 | 67 | 2 | 536 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 7.14e-10 | 189 | 105 | 9 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-07 | 179 | 105 | 7 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-07 | 184 | 105 | 7 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-07 | 189 | 105 | 7 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.44e-07 | 190 | 105 | 7 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.44e-07 | 190 | 105 | 7 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.96e-07 | 194 | 105 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-07 | 196 | 105 | 7 | f6df26ab9eebae893768a4f70a064ce9f60da93c | |
| ToppCell | facs-Lung-ENDOMUCIN|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-07 | 196 | 105 | 7 | 69f03546c42c942ab8ac8746167c8d44d574b4c6 | |
| ToppCell | facs-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.70e-07 | 199 | 105 | 7 | c11e0044d3cc37f6bb26df033ad4448b419addfc | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.86e-07 | 200 | 105 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.86e-07 | 200 | 105 | 7 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.86e-07 | 200 | 105 | 7 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.86e-07 | 200 | 105 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.86e-07 | 200 | 105 | 7 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.86e-07 | 200 | 105 | 7 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.58e-06 | 151 | 105 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.47e-06 | 163 | 105 | 6 | b0aa4a620bd58011225b42ea6dda04e3101ba342 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.84e-06 | 176 | 105 | 6 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-06 | 179 | 105 | 6 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.66e-06 | 182 | 105 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 4.66e-06 | 182 | 105 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 183 | 105 | 6 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-06 | 184 | 105 | 6 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.96e-06 | 184 | 105 | 6 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 5.12e-06 | 185 | 105 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.12e-06 | 185 | 105 | 6 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 185 | 105 | 6 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 5.12e-06 | 185 | 105 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.28e-06 | 186 | 105 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 187 | 105 | 6 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-06 | 187 | 105 | 6 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 5.44e-06 | 187 | 105 | 6 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 5.61e-06 | 188 | 105 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.61e-06 | 188 | 105 | 6 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-06 | 188 | 105 | 6 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.61e-06 | 188 | 105 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.78e-06 | 189 | 105 | 6 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.78e-06 | 189 | 105 | 6 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 5.78e-06 | 189 | 105 | 6 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.78e-06 | 189 | 105 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.78e-06 | 189 | 105 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 189 | 105 | 6 | 2a5fda73d38bdc23cf47e5335ffd4e086e990245 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 5.78e-06 | 189 | 105 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-06 | 190 | 105 | 6 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 6.14e-06 | 191 | 105 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-06 | 191 | 105 | 6 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.14e-06 | 191 | 105 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.14e-06 | 191 | 105 | 6 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.14e-06 | 191 | 105 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 6.14e-06 | 191 | 105 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 6.33e-06 | 192 | 105 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.33e-06 | 192 | 105 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.33e-06 | 192 | 105 | 6 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.33e-06 | 192 | 105 | 6 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 6.33e-06 | 192 | 105 | 6 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 6.33e-06 | 192 | 105 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-06 | 193 | 105 | 6 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 6.52e-06 | 193 | 105 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-06 | 193 | 105 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-06 | 193 | 105 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-06 | 193 | 105 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.52e-06 | 193 | 105 | 6 | 0f2967afbbf4e538b63f985c0acc2e5d9aab7589 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-06 | 193 | 105 | 6 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-06 | 194 | 105 | 6 | f76808666fb875fc787751cbfd924d9be20a8192 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-06 | 194 | 105 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-06 | 194 | 105 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.72e-06 | 194 | 105 | 6 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.72e-06 | 194 | 105 | 6 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-06 | 194 | 105 | 6 | f5706ab6bc803606c4640ddd606617e4e797ccc9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-06 | 194 | 105 | 6 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 6.92e-06 | 195 | 105 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.92e-06 | 195 | 105 | 6 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 195 | 105 | 6 | 52b2bbf12e5f86c493f6634697aeb23a68cc916d | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 195 | 105 | 6 | e5f14f6015ea5e6fa065f906ad22157e3de15c68 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 195 | 105 | 6 | 5b84fd5be31386eb1d6048bbf28626032361842e | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 6.92e-06 | 195 | 105 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 195 | 105 | 6 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 196 | 105 | 6 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 196 | 105 | 6 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.12e-06 | 196 | 105 | 6 | 97324c9e93f833e1f218e81fb53066d44c6892df | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 196 | 105 | 6 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.12e-06 | 196 | 105 | 6 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 7.12e-06 | 196 | 105 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.12e-06 | 196 | 105 | 6 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 196 | 105 | 6 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.33e-06 | 197 | 105 | 6 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-06 | 197 | 105 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 197 | 105 | 6 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-06 | 197 | 105 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 197 | 105 | 6 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 7.33e-06 | 197 | 105 | 6 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-06 | 197 | 105 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-06 | 197 | 105 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | wk_20-22-Epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.33e-06 | 197 | 105 | 6 | 468071c1911cdf8e8806a78dbceb95379e28ae91 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 197 | 105 | 6 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.33e-06 | 197 | 105 | 6 | b18f2c14d6720f6ae8520c0800356f4a57393ad3 | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A | 4.00e-06 | 199 | 105 | 8 | 4539_UP | |
| Disease | Malignant melanoma of iris | 4.11e-07 | 5 | 103 | 3 | C0346373 | |
| Disease | Malignant melanoma of choroid | 4.11e-07 | 5 | 103 | 3 | C0346388 | |
| Disease | Uveal melanoma | 2.28e-06 | 8 | 103 | 3 | C0220633 | |
| Disease | Ewings sarcoma | 2.28e-06 | 8 | 103 | 3 | C0553580 | |
| Disease | obesity (implicated_via_orthology) | 1.08e-05 | 215 | 103 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Hypoxic Brain Damage | 1.21e-05 | 2 | 103 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 1.21e-05 | 2 | 103 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 1.21e-05 | 2 | 103 | 2 | C1527348 | |
| Disease | Phakomatosis cesioflammea | 1.21e-05 | 2 | 103 | 2 | C3838883 | |
| Disease | Anoxia of brain | 1.21e-05 | 2 | 103 | 2 | C0995195 | |
| Disease | Congenital hemangioma | 1.21e-05 | 2 | 103 | 2 | C0235753 | |
| Disease | Port-wine stain with oculocutaneous melanosis | 1.21e-05 | 2 | 103 | 2 | C1274879 | |
| Disease | Extra-osseous Ewing's sarcoma | 7.21e-05 | 4 | 103 | 2 | C0279980 | |
| Disease | neutrophil count | EYA4 PCDHA9 ERG OLFML2B ETV3 PCDHA13 PCDHA12 MYO1B SLAMF1 SLC45A4 ITPR2 POLI SSBP4 AGBL2 DOCK6 | 8.98e-05 | 1382 | 103 | 15 | EFO_0004833 |
| Disease | Hypoplastic Left Heart Syndrome | 1.20e-04 | 5 | 103 | 2 | C0152101 | |
| Disease | 1,5 anhydroglucitol measurement | 1.41e-04 | 29 | 103 | 3 | EFO_0008009 | |
| Disease | multiple sclerosis | 2.39e-04 | 594 | 103 | 9 | MONDO_0005301 | |
| Disease | melanoma | 2.40e-04 | 248 | 103 | 6 | C0025202 | |
| Disease | visceral adipose tissue measurement | 2.89e-04 | 481 | 103 | 8 | EFO_0004765 | |
| Disease | N-acetylneuraminate measurement | 3.33e-04 | 8 | 103 | 2 | EFO_0020022 | |
| Disease | Malignant neoplasm of breast | GPC1 ERBB4 TFPI2 ETV4 TRMT11 PFKFB4 SLAMF1 ATP6AP1L ELK3 DNAH9 PURG SORL1 | 3.70e-04 | 1074 | 103 | 12 | C0006142 |
| Disease | Cutaneous Melanoma | 4.00e-04 | 41 | 103 | 3 | C0151779 | |
| Disease | Mental deterioration | 4.28e-04 | 9 | 103 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 4.28e-04 | 9 | 103 | 2 | C1270972 | |
| Disease | susceptibility to urinary tract infection measurement | 5.68e-04 | 108 | 103 | 4 | EFO_0008413 | |
| Disease | trimethyllysine measurement | 6.50e-04 | 11 | 103 | 2 | EFO_0009134 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 7.78e-04 | 12 | 103 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 7.98e-04 | 702 | 103 | 9 | C0009402 | |
| Disease | breast carcinoma | SEC16B ERBB4 ADAM29 CHST9 SSBP2 PFKFB4 ATP6AP1L ITPR1 ROPN1L GNAQ SSBP4 | 8.70e-04 | 1019 | 103 | 11 | EFO_0000305 |
| Disease | hypoxanthine mesurement | 1.07e-03 | 14 | 103 | 2 | EFO_0010500 | |
| Disease | trimethylamine-N-oxide measurement | 1.07e-03 | 14 | 103 | 2 | EFO_0010541 | |
| Disease | Impaired cognition | 1.07e-03 | 14 | 103 | 2 | C0338656 | |
| Disease | neutrophil count, basophil count | 1.15e-03 | 224 | 103 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | B-cell acute lymphoblastic leukemia | 1.23e-03 | 15 | 103 | 2 | EFO_0000094 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 1.25e-03 | 228 | 103 | 5 | EFO_0003948, MONDO_0004975 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 1.59e-03 | 17 | 103 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | mean arterial pressure | 1.86e-03 | 499 | 103 | 7 | EFO_0006340 | |
| Disease | hippocampal tail volume | 1.99e-03 | 19 | 103 | 2 | EFO_0009398 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDSIKNYYRKYSAVR | 151 | Q0P6H9 | |
| IDNYLYIRYERNDSK | 206 | Q9UKF5 | |
| YEDRYALAIFLNYRK | 111 | Q15303 | |
| NYDKLSRALRYYYDK | 56 | P19419 | |
| RYYKERLLYLEEGQK | 311 | Q9NR81 | |
| NYDKLSRALRYYYDK | 361 | P11308 | |
| NYDKLSRALRYYYNK | 86 | P41162 | |
| RYILFKEYDLYGQEL | 571 | Q8WXK1 | |
| KQYEAARLEYDAYRT | 226 | P53365 | |
| LKYLLLTYYDANKRD | 36 | Q8N2N9 | |
| SREQLLYLYARYKQV | 61 | Q9BR61 | |
| NYDKLSRSLRYYYEK | 391 | P43268 | |
| DYDLKYCYVDRNKRT | 91 | Q9HCJ3 | |
| YKNYYSLVLDRALDR | 401 | Q9Y5H5 | |
| YYRLVTRKYLDRENV | 401 | Q9Y5G5 | |
| DRRREYQLSDSTKYY | 146 | P50148 | |
| KADLEVLTYYRYQLN | 721 | Q14571 | |
| GKYEAVERYYQRALA | 351 | Q9NSK0 | |
| YLLKNYDRFHYLLDN | 486 | Q09327 | |
| EDRDVLSYYRYQLNL | 726 | Q14643 | |
| FRDLYSELRLYYRGA | 141 | P35052 | |
| YNKAIDYYLKALRSL | 936 | Q3B7T1 | |
| RYYLRKLNLDGSNYT | 3036 | Q07954 | |
| NKYRLADDLYRYDVD | 526 | O75882 | |
| DYRYRSYSSVIEKAL | 11 | Q9Y3R5 | |
| SYKVRLVLYGERYND | 971 | Q8IY21 | |
| YLYLDKIYCLLSVRN | 11 | A8MZ26 | |
| LEFALRDQDKYRYRY | 346 | Q16877 | |
| LESDYEYEYLLALRL | 2011 | O94915 | |
| RAKYVTYQYDLELDR | 546 | Q8IY47 | |
| TDYLKNTYRLKLYSL | 46 | P27487 | |
| DLAQLLLRLDYNKYY | 641 | Q9UGJ1 | |
| KNVSIEDYYELLYRV | 191 | Q969J5 | |
| AGEAYLVYTDRLYSR | 71 | O43688 | |
| YKRYRVRSYEAVAAA | 221 | Q9BQ04 | |
| RLSSYIKRYVELTNY | 86 | Q5VYS4 | |
| YILDLQDRNTASKYY | 901 | Q9UG01 | |
| YKNYYSLVLDSALDR | 401 | Q9Y5I0 | |
| IYTAVKLNREVRDYY | 771 | Q96QU1 | |
| LAFRYRRVKELYNTY | 481 | O95677 | |
| TYELKDRVTYFDRNY | 1831 | Q96HP0 | |
| YKFSYSNLKEYSRLL | 81 | Q8N0S6 | |
| LERYYYYLTNGIRKD | 231 | Q8TD57 | |
| YIRRLDSDDRLYEAY | 336 | Q6P4F1 | |
| ARYIELLTRSGDYYR | 1001 | P15924 | |
| DRRREYQLSDSAKYY | 146 | P29992 | |
| NYDKLSRALRYYYDK | 331 | Q01543 | |
| YEYELTLRTDLYTNK | 286 | Q5U5Z8 | |
| YDKLSRALRYYYDKN | 56 | P41970 | |
| YYERQQSDLDKYIIL | 96 | Q16798 | |
| ALEDDRLRKYYLGKY | 896 | Q86Z14 | |
| ELYSYAKDLFLQRYQ | 486 | Q96MM7 | |
| LGRRQNDSLDKYYYA | 241 | A4D0S4 | |
| KSRYEDLKYIYNQLR | 256 | Q9NYC9 | |
| YDKLSRALRYYYNKR | 91 | Q6ZN32 | |
| DRTYKLSCRILYQYL | 201 | Q99675 | |
| YSYYLDNRLKDERIS | 621 | Q9UNA4 | |
| ILLKSRYDVRAYYVE | 2296 | Q6ZTR5 | |
| LYLSERYAELYRRQQ | 46 | Q5T953 | |
| YKNYYSLVLDSALDR | 401 | Q9UN75 | |
| LKTDYIERDNRKYYL | 171 | Q9UJV8 | |
| DYRKNNTYLVKRLEY | 146 | Q6P4E1 | |
| YDRRREYQLSDSAKY | 141 | O95837 | |
| RNLLYEYAREGYSAL | 41 | Q9NP81 | |
| RYSEFELLRSYLLVY | 106 | O95219 | |
| SQAREKLALYVYEYL | 16 | P81877 | |
| ILYAVRKSIYRYDLA | 761 | Q92673 | |
| RANLRQYGLEKYYLD | 271 | Q7Z4G4 | |
| YYSLLDVFYNRLLKS | 341 | Q8N3R3 | |
| EFVDYYYSTNRKRVL | 176 | O75151 | |
| RAKRKVRYSEDYLYD | 481 | Q5QGS0 | |
| YLGDRYKFYLENLTL | 91 | Q13291 | |
| AIYYLLLERLKEYRN | 336 | A0A0B4J2F2 | |
| AIYYLLLERLKEYRN | 336 | P57059 | |
| YYNRAFTRNIIKYDL | 576 | Q68BL8 | |
| DKDAYYRRVKRLYSN | 6 | Q9Y5B9 | |
| DGRLLEYYRLYNTLD | 296 | Q6UX06 | |
| EYYRLYNTLDDLLLY | 301 | Q6UX06 | |
| SRLYARYFQGDLKLY | 331 | Q15120 | |
| DLTRTERQLIYDFYY | 416 | Q7L1S5 | |
| RYSRYLNEKAVSYRQ | 126 | Q13492 | |
| KYLDNYDLSVRVIYV | 581 | Q5BKX6 | |
| YYDNDALRDRYLGLQ | 596 | Q92959 | |
| LRARRLYQLAYDTYQ | 41 | P01242 | |
| RYLVYGDEYKALRDA | 4326 | Q63HN8 | |
| KTFSYVYRYLARLDS | 166 | Q96C74 | |
| YENYRSRKLAAVTYN | 306 | Q16181 | |
| RIYNDDKNTYIRYEL | 1286 | O75533 | |
| QAREKLALYVYEYLL | 16 | Q9BWG4 | |
| LKYLEDNRILTYQYG | 436 | O43280 | |
| RQSQALILKIADYYY | 116 | Q5SRE5 | |
| DDLIFKLAYYEIRYQ | 3376 | Q709C8 | |
| ARDIYKNDYYRKRGE | 2106 | P08922 | |
| IYGERLYETSYRLSK | 211 | Q9UKN8 | |
| FQVYKLLYASRLADY | 626 | Q96JE7 | |
| LSYILLDLRNYYIKE | 171 | Q9Y2C9 | |
| HQRLLEYLKYTLDQY | 51 | P85298 | |
| DEEYYRKQLSYFDRR | 1351 | Q07157 | |
| YICELALALEYLQRY | 126 | Q9NY57 | |
| RALLLRYYYDRYTQS | 46 | P48307 | |
| YAYLDILLYFTRQKD | 291 | Q14139 | |
| AYDLARRAIYQATYR | 211 | P28074 | |
| IYLRYLDQQYDLIAS | 171 | Q52LC2 | |
| KELYLIRYNNYDRAV | 326 | Q9NVH6 | |
| TIRRNYIYEDAYDKL | 726 | Q15386 | |
| YYARDALAKNLYSRL | 346 | O43795 | |
| HQLQKRYADLLIYTY | 361 | Q8WXR4 |